NOTES TO CONDENSED FINANCIAL STATEMENTS
(unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
InterPrivate IV InfraTech Partners Inc. (the “Company”)
is a blank check company incorporated in Delaware on September 10, 2020. It was originally incorporated under the name “InterPrivate
III Technology Partners Corp.”, but the Company changed its name to “InterPrivate IV InfraTech Partners Inc.” on January
6, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or other similar business combination with one or more businesses (each, a “Business Combination”).
The Company is not limited to a particular industry
or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2022, the Company had not commenced
any operations. All activity through June 30, 2022 relates to the Company’s formation, its initial public offering (the “Initial
Public Offering”), and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company
will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company
will generate non-operating income on cash and cash equivalents in the form of interest income from the proceeds derived from the Initial
Public Offering. The Company has selected December 31 as its fiscal year end.
The registration statement for the Initial Public
Offering was declared effective on March 4, 2021. On March 9, 2021, the Company consummated the Initial Public Offering of 28,750,000
units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public
Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 3,750,000 Units,
at $10.00 per Unit, generating gross proceeds of $287,500,000, which is described in Note 3.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 5,000,000 warrants (each, a “Private Placement Warrant” and, collectively,
the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to InterPrivate
Acquisition Management IV, LLC (the “Sponsor”), generating gross proceeds of $7,500,000, which is described in Note 4.
Following the closing of the Initial Public Offering
on March 9, 2021, an amount of $287,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering
and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), and was invested in U.S.
government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment
Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money
market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of:
(i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s
stockholders, as described below.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Nasdaq
Stock Market LLC (“Nasdaq”) rules provide that the Business Combination must be with one or more target businesses that together
have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes
payable on interest earned on the Trust Account) at the time of the signing of a definitive agreement to enter into a Business Combination.
The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding
voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect
a Business Combination.
The Company will provide the holders of the outstanding
Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the
completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination
or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination
or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their
Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption
rights upon the completion of a Business Combination with respect to the Company’s warrants.
If the Company seeks stockholder approval, the
Company will proceed with a Business Combination only if a majority of the shares voted are voted in favor of the Business Combination.
If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons,
the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”),
conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file
tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is
required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem
shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. The Company will
not redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If the Company seeks stockholder
approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public
Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and not to convert any shares
in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection
with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they
vote for or against the proposed transaction or do not vote at all.
Notwithstanding the above, if the Company seeks
stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and
Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other
person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more
than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption
rights with respect to the Founder Shares and Public Shares held by the Sponsor in connection with the completion of a Business Combination
and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or
timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to
redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision
relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders
with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares
in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the
Company fails to complete a Business Combination.
The Company will have until March 9, 2023 or any
extended period of time that the Company may have to consummate a Business Combination as a result of an amendment to the Company’s
Amended and Restated Certificate of Incorporation to complete a Business Combination (the “Combination Period”). If the Company
is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for
the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned
on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest
to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public
stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the
Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law
to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions
with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within
the Combination Period.
The Sponsor has agreed to waive its liquidation
rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However,
if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions
from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed
to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not
complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds
held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is
possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price
per Unit ($10.00).
In order to protect the amounts held in the Trust
Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or
products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement,
reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) the actual amount per Public Share
held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in
each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any
claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under
the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to
be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.
The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by
endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective
target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title,
interest or claim of any kind in or to monies held in the Trust Account.
Risks and Uncertainties
Management continues to evaluate the impact of
the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s
financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the financial
statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or
omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, the financial statements do not
include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash
flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of
a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for
the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as
filed with the SEC on April 1, 2022 (the “Annual Report”). The interim results for the three and six months ended June 30,
2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.
Certain reclassifications were made to the prior
period balances to conform to the current period presentation. These reclassifications do not restate the prior year financial statements
and are for presentation purposes only.
Liquidity and Financial Condition
As of June 30, 2022, the Company had cash of $79,522 and a working
capital deficit of $2,310,810. The Company will need to raise additional capital through loans or additional investments from its initial
stockholders, officers or directors. If the Company is unable to raise additional capital, the Company may be required to take additional
measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit
of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available
to the Company on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability
to continue as a going concern through one year and one day from the issuance of this report. The Company has a termination date of less
than one year from the issuance of this report which will result in a mandatory liquidation.
Offering Costs Associated with the Initial
Public Offering
The Company complies with the requirements of
the Accounting Standards Codification (“ASC”) 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “Expenses
of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that
are related to the Initial Public Offering and were charged to stockholders’ equity upon the completion of the Initial Public Offering.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging
growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth
company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting
standards used.
Use of Estimates
The preparation of the condensed financial statements
in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near
term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of June 30, 2022 and December 31, 2021.
Marketable Securities Held in Trust Account
At June 30, 2022, substantially all of the assets
held in the Trust Account were invested in U.S. Treasury Bills.
Class A Common Stock Subject to Possible
Redemption
The Company accounts for its Class A common stock subject to possible
redemption in accordance with the guidance in ASC 480. Class A common stock subject to mandatory redemption is classified as a liability
instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights
that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the
Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity.
The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control
and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2022, Class A common stock subject to possible redemption
is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.
Income Taxes
The Company complies with the accounting and reporting
requirements of ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial
accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial
statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws
and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were
no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2022 and December 31, 2021. The Company
is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is subject to income tax examinations by major taxing authorities since inception.
Our effective tax rate was 1.1% and 0.00%
for the three months ended June 30, 2022 and 2021, respectively, and 1.1% and 0.00% for the six months ended June 30, 2022 and 2021, respectively.
The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2022 and 2021, due to changes
in fair value in warrant liability and the valuation allowance on the deferred tax assets.
Net Income (Loss) Per Share of Common Stock
The Company complies with accounting and disclosure
requirements of ASC Topic 260, “Earnings Per Share” (“ASC Topic 260”). Net income (loss) per common share is computed
by dividing net income by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable
shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of
basic and diluted net income (loss) per common share (in dollars, except per share amounts):
| |
For the three months ended | | |
For the six months ended | |
| |
June 30, | | |
June 30, | |
| |
2022 | | |
2021 | | |
2022 | | |
2021 | |
Class A common stock subject to possible redemption | |
| | |
| | |
| | |
| |
| |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Net income (loss) allocable to Class A common stock subject to possible redemption | |
$ | 2,224,257 | | |
$ | (3,340,015 | ) | |
$ | 4,604,552 | | |
$ | (3,332,033 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | |
| 28,750,000 | | |
| 28,750,000 | | |
| 28,750,000 | | |
| 17,948,895 | |
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption | |
| 0.08 | | |
| (0.12 | ) | |
| 0.16 | | |
| (0.19 | ) |
| | For the three months ended June 30, | | | For the six months ended six June 30, | |
Non-redeemable common stock | | 2022 | | | 2021 | | | 2022 | | | 2021 | |
| | | | | | | | | | | | |
Numerator: | | | | | | | | | | | | |
Net income (loss) | | $ | 2,780,321 | | | $ | (4,175,019 | ) | | $ | 5,755,690 | | | $ | (4,427,860 | ) |
Less: Net income (loss) allocable to Class A common stock subject to possible redemption | | | (2,224,257 | ) | | | 3,340,015 | | | | (4,604,552 | ) | | | 3,332,033 | |
Net income (loss) allocable to non-redeemable common stock | | $ | 556,064 | | | | (835,004 | ) | | $ | 1,151,138 | | | | (1,095,827 | ) |
Denominator: | | | | | | | | | | | | | | | | |
Basic and diluted weighted average shares outstanding, non-redeemable common stock | | | 7,187,500 | | | | 7,187,500 | | | | 7,187,500 | | | | 5,902,970 | |
Basic and diluted net income (loss) per share, non-redeemable common stock | | | 0.08 | | | | (0.12 | ) | | | 0.16 | | | | (0.19 | ) |
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal
Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement” (“ASC 820”),
approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
NOTE 3. PUBLIC OFFERING
There have been no changes to the public offering
amounts previously disclosed in the December 31, 2021 financials. As of June 30, 2022, cash of $79,522 was held outside of the Trust Account
and was available for working capital purposes.
NOTE 4. PRIVATE PLACEMENT
There have been no changes to the private placement
amounts previously disclosed in the December 31, 2021 financials.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
There have been no changes to the Founder Shares amounts previously
disclosed in the December 31, 2021 financials.
Convertible Promissory Note — Related
Party
On March 31, 2022, the Company entered into a
convertible promissory note with the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $1,500,000
(the “Convertible Promissory Note”). The Convertible Promissory Note is non-interest bearing and due on the earlier of March
9, 2023 and the date on which the Company consummates its initial business combination. If we complete a business combination, we would
repay such additional loaned amounts, without interest, upon consummation of the business combination. In the event that a business combination
does not close, we may use a portion of the working capital held outside the Trust Account to repay such additional loaned amounts but
no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such additional loans (if any) may be convertible
into warrants, at a price of $1.50 per warrant at the option of the Sponsor. The warrants would be identical to the private placement
warrants, including as to exercise price, exercisability and exercise period. Except for the foregoing, the terms of such additional loans
(if any) have not been determined and no written agreements exist with respect to such loans. If we fully draw down on the Convertible
Promissory Note and require additional funds for working capital purposes, the Sponsor, an affiliate of the Sponsor, or our officers and
directors may, but are not obligated to, loan us such additional funds as may be required. The issuance of the Convertible Promissory
Note was approved by our board of directors and our audit committee on March 31, 2022. As of June 30, 2022, $451,538 was outstanding under
the Convertible Promissory Note which is included in related party payable on the accompanying condensed balance sheets.
Related Party Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a
Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may
be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical
to the Private Placement Warrants.
In addition, as the Company incurs operating expenses,
these fees are paid by InterPrivate LLC, and InterPrivate LLC is subsequently reimbursed by the Company for the full amount paid. As of
June 30, 2022, the Company had outstanding related party payables due to the Sponsor of $0.
Administrative Services Agreement
The Company entered into an agreement, commencing
on March 4, 2021, pursuant to which the Company will pay the Sponsor a total of $10,000 per month for office space, administrative and
support services. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate, and the
Company will cease paying these monthly fees. For both the three months ended June 30, 2022 and 2021, the Company recorded $30,000 per
period in fees for these services. For the six months ended June 30, 2022 and 2021, the Company recorded $60,000 and $40,000, respectively,
in fees for these services. As of June 30, 2022, the administrative service fee payable was $30,000, and is included in related party
payable on the accompanying condensed balance sheets.
Services Agreement
The Company entered into an agreement, pursuant
to which the Company will pay its Vice President a total of $10,000 per month for assisting the Company in negotiating and consummating
an initial business combination. Upon completion of the Business Combination or the Company’s liquidation, the agreement will terminate,
and the Company will cease paying these monthly fees. For both the three months ended June 30, 2022 and 2021, the Company recorded $30,000
per period in fees for these services. For the six months ended June 30, 2022 and 2021, the Company recorded $60,000 and $40,000, respectively,
in fees for these services. As of June 30, 2022, the service fee payable was $30,000, and is included in related party payable on the
accompanying condensed balance sheets.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
Pursuant to a registration rights agreement entered
into on March 4, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion
of the Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants
and warrants that may be issued upon conversion of Working Capital Loans) have registration rights requiring the Company to register a
sale of any of the securities held by them prior to the consummation of a Business Combination. The holders of these securities will be
entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition,
the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the
completion of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions
resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred fee
of $0.35 per Unit, or $10,062,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in
the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
NOTE 7. WARRANTS
There have been no changes to the public warrant
disclosure since the December 31, 2021 financials.
NOTE 8. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820 for
its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets
and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
|
|
|
|
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|
|
|
|
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
The following tables present information about
the Company’s assets that are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021, respectively,
and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| |
| | |
June 30, | |
Description | |
Level | | |
2022 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 287,798,366 | |
| |
| | | |
| | |
Liabilities: | |
| | | |
| | |
Warrant liability - Public Warrants | |
| 3 | | |
| 1,438,075 | |
Warrant liability - Private Placement Warrants | |
| 3 | | |
| 1,250,500 | |
| |
| | |
December 31, | |
Description | |
Level | | |
2021 | |
Assets: | |
| | |
| |
Marketable securities held in Trust Account | |
| 1 | | |
$ | 287,579,158 | |
| |
| | | |
| | |
Liabilities: | |
| | | |
| | |
Warrant liability - Public Warrants | |
| 3 | | |
| 4,658,299 | |
Warrant liability - Private Placement Warrants | |
| 3 | | |
| 4,081,300 | |
The Public Warrants and the Private Placement
Warrants were initially valued using a Binomial Lattice Model, which is considered to be a Level 3 fair value measurement. The Binomial
Lattice Model’s primary unobservable input utilized in determining the fair value of the Public Warrants and the Private Placement
Warrants is the expected volatility of the common stock. The expected volatility as of the IPO date was derived from observable public
warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent
valuation dates was implied from the Company’s own public warrant pricing. A Binomial Lattice Model was used in estimating the fair
value of the Public Warrants for periods where no observable traded price was available, using the same expected volatility as was used
in measuring the fair value of the Private Placement Warrants. For periods subsequent to the detachment of the Public Warrants from the
Units, the closing price of the Public Warrants was used as the fair value of the Public Warrants as of each relevant date.
The key inputs into the Binomial Lattice Model
for the initial measurement of the Public Warrants and the Private Placement Warrants, and the subsequent measurement of the Private Placement
Warrants, are as follows:
| |
June 30, | | |
December 31, | |
Term | |
2022 | | |
2021 | |
Risk-free interest rate | |
| 2.97 | % | |
| 1.19 | % |
Market price of public stock | |
$ | 9.80 | | |
$ | 9.70 | |
Dividend yield | |
| 0 | % | |
| 0 | % |
Implied volatility | |
| 6.70 | % | |
| 16.60 | % |
Exercise price | |
$ | 11.50 | | |
$ | 11.50 | |
The above assumptions are based on an expected
close of a de-SPAC transaction on February 28, 2023.
On June 30, 2022 and December 31, 2021, the Private
Placement Warrants were determined to be valued at $0.25 and $0.82 per warrant, respectively. On June 30, 2022 and December 31, 2021,
the Public Warrants were valued at $0.25 and $0.81 per warrant, respectively.
The following table presents the changes in the
fair value of warrant liabilities:
Term | |
Public
Warrants | | |
Private
Placement
Warrants | |
Fair value as of December 31, 2021 | |
| 4,658,299 | | |
| 4,081,300 | |
Change in valuation inputs or other assumptions | |
| (3,220,224 | ) | |
| (2,830,800 | ) |
Fair value as of June 30, 2022 | |
| 1,438,075 | | |
| 1,250,500 | |
During the three-month period ended June
30, 2022, there were no transfers out of Level 3.
NOTE 9. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred
after the balance sheet date up to the date that the condensed financial statements were issued. The Company did not identify any subsequent
events that would have required adjustment or disclosure in the condensed financial statements.